CN107468857A - 一种能够治疗胃溃疡的中药制备方法 - Google Patents
一种能够治疗胃溃疡的中药制备方法 Download PDFInfo
- Publication number
- CN107468857A CN107468857A CN201710756331.1A CN201710756331A CN107468857A CN 107468857 A CN107468857 A CN 107468857A CN 201710756331 A CN201710756331 A CN 201710756331A CN 107468857 A CN107468857 A CN 107468857A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- decoction
- gastric ulcer
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000007107 Stomach Ulcer Diseases 0.000 title claims abstract description 27
- 201000005917 gastric ulcer Diseases 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 61
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229940079593 drug Drugs 0.000 claims abstract description 21
- 239000009636 Huang Qi Substances 0.000 claims abstract description 16
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 13
- 244000235603 Acacia catechu Species 0.000 claims abstract description 13
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 13
- 244000197580 Poria cocos Species 0.000 claims abstract description 13
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 13
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 13
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 13
- 241000271897 Viperidae Species 0.000 claims abstract description 13
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 13
- 235000005412 red sage Nutrition 0.000 claims abstract description 13
- 239000000454 talc Substances 0.000 claims abstract description 13
- 229910052623 talc Inorganic materials 0.000 claims abstract description 13
- 235000012222 talc Nutrition 0.000 claims abstract description 13
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 12
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 12
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 12
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 12
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 12
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 12
- 241001522129 Pinellia Species 0.000 claims abstract description 12
- 238000007654 immersion Methods 0.000 claims abstract description 11
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 10
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 8
- 240000001949 Taraxacum officinale Species 0.000 claims abstract description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 210000003298 dental enamel Anatomy 0.000 claims description 2
- 229910001220 stainless steel Inorganic materials 0.000 claims description 2
- 239000010935 stainless steel Substances 0.000 claims description 2
- 210000002784 stomach Anatomy 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 230000007246 mechanism Effects 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 206010067482 No adverse event Diseases 0.000 abstract 1
- 241000245665 Taraxacum Species 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 210000001156 gastric mucosa Anatomy 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010019375 Helicobacter infections Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000001114 myogenic effect Effects 0.000 description 2
- 208000011906 peptic ulcer disease Diseases 0.000 description 2
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 2
- 229960000620 ranitidine Drugs 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010017815 Gastric perforation Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 101150056637 Hrh2 gene Proteins 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229960003174 lansoprazole Drugs 0.000 description 1
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- OJLOPKGSLYJEMD-URPKTTJQSA-N methyl 7-[(1r,2r,3r)-3-hydroxy-2-[(1e)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl]heptanoate Chemical compound CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC OJLOPKGSLYJEMD-URPKTTJQSA-N 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- 229960005249 misoprostol Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 229940126409 proton pump inhibitor Drugs 0.000 description 1
- 239000000612 proton pump inhibitor Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种能够治疗胃溃疡的中药制备方法,括以下几个步骤:以重量份计,称取蒲公英12~16份、黄芪12~20份、滑石15~19份、白花蛇10~12份、半夏10~15份、丹参10~16份、乌贼骨6~12份、桂枝6~10份、山药12~16份、茯苓10~18份、田七12~16份、儿茶8~14份;将上述全部中药原料药,先行用清水或纯净水浸泡;将浸泡后的中药原料药物及其浸泡的药水加入到煎药容器中,加盖共同煎熬;煎煮完成后,滤出药液,所获药液即为内服药物。本发明的有益效果是:本发明是基于对胃溃疡症状机理的认识及治疗原则,采用直接口服的方法,攻补兼施,具有强健脾胃、活血化瘀、益气养胃的效果,疗效显著,质量容易控制,稳定性好,基本无不良反应。
Description
技术领域
本发明涉及中药领域,具体的说,是一种能够治疗胃溃疡的中药制备方法。
背景技术
胃溃疡是临床最为常见的一种消化系统疾病,患者主要表现为上腹部慢性、规律性疼痛。胃溃疡的发生与遗传、生活(长期饮酒或服用非甾体类抗炎药、饮食不规律)、精神因素(精神紧张、焦虑)有关,近年来,研究表明,幽门螺杆菌感染是胃溃疡发生的重要致病原因,因此,在治疗胃溃疡时,抗幽门螺杆菌感染也为关键。胃溃疡病易复发,病程长,给患者的生活质量造成严重的影响。而且胃溃疡病情发展易发生各种并发症,如胃穿孔、胃癌等。随着人们生活节奏的加快,人们长期饮食不规律、精神紧张、过度劳累,均造成了胃溃疡发病率逐年上升,已成为严重危害人类健康的重要疾病之一。
根据胃溃疡的发病原因及发病特点,目前胃溃疡的西医治疗的主要药物包括抗酸剂(碳酸氢钠、氢氧化钠)、质子泵抑制剂(奥美拉唑、兰索拉唑等)、H2受体阻断剂(西米替丁、雷尼替丁、法莫替丁等)、胃黏膜保护剂(米索前列醇等)、抗幽门螺杆菌类药(甲硝唑等),但西医治疗具有治疗效果不理想,副作用大,易复发的缺点。中医认为,胃溃疡发病的根本因素为脾胃虚弱,发病的重要病理环节为瘀热,胃溃疡患者多表现为虚实夹杂、寒热错杂。近年来,对于胃溃疡的中医治疗也逐渐引起人们的关注和重视,市场上也出现了较多的治疗胃溃疡的中药制剂,如黄芪建中丸、柴胡疏肝丸、胃得安胶囊等,但这些中药成分复杂,患者在长期服用后,仍会引起不良反应。
发明内容
本发明的目的在于提供一种疗效显著、见效快、无副作用的能够治疗胃溃疡的中药制备方法。
本发明通过下述技术方案实现:一种能够治疗胃溃疡的中药制备方法,包括以下几个步骤:
步骤S1:以重量份计,称取蒲公英12~16份、黄芪12~20份、滑石15~19份、白花蛇10~12份、半夏10~15份、丹参10~16份、乌贼骨6~12份、桂枝6~10份、山药12~16份、茯苓10~18份、田七12~16份、儿茶8~14份、黄芪10~16份;
步骤S2:将上述全部中药原料药,先行用清水或纯净水浸泡30分钟,浸泡用水量为0.9~1.1L;
步骤S3:将浸泡后的中药原料药物及其浸泡的药水加入到煎药容器中,加盖共同煎熬;
步骤S4:先用武火使煎药容器中药液沸腾,再使用文火熬制15~20分钟,煎药时需搅拌2~3次;
步骤S5:煎煮完成后,滤出药液,所获药液即为内服药物。
所述的步骤S3包括以下几个步骤:
步骤S301:先将蒲公英、黄芪、滑石、白花蛇加入到煎药容器中以小火煎煮10分钟;
步骤S302:再将半夏、丹参、乌贼骨、桂枝加入到煎药容器中以小火煎煮10分钟;
步骤S303:再将山药、茯苓、田七、儿茶加入到煎药容器中。
所述的步骤S2~S5为第一次煎煮,还包括步骤S6:
采用0.7~0.8L清水或纯净水重复步骤S3~S5进行第二次煎煮;
采用0.5~0.6L清水或纯净水重复步骤S3~S5进行第三次煎煮。
所述的第一次煎煮进行两小时,第二次煎煮进行一小时,第三次煎煮进行一小时。
所述的煎药容器为砂锅、搪瓷器皿或者不锈钢,忌用铁器。
本发明所述的一种能够治疗胃溃疡的中药配方的原料药药理:
蒲公英:性寒,味苦、甘。归肝经、胃经。清热解毒,利尿散结。属清热药下分类的清热解毒药。
黄芪:性微温,味甘。归脾经、肺经。补气固表、利尿、托毒排脓、生肌。属补虚药下属分类的补气药。
滑石:性寒,味甘、淡。归膀胱经、肺经、胃经。利尿通淋、清热解暑,外用祛湿敛疮。属利水渗湿药下属分类的利尿通淋药。
白花蛇:性凉,味微苦、微甘。归胃经、大肠经、小肠经。清热、利湿、解毒、抗癌。属清热药下属中的清热解毒药。
半夏:性温,味辛,有毒。归脾经、胃经、肺经。燥湿化痰、降逆止呕、消痞散结。属清热药下属分类的清热燥湿药。
丹参:性微寒,味苦。归心经、肝经。祛瘀止痛、活血痛经、清心除烦。属活血化瘀药下分类的活血调经药。
乌贼骨:咸、涩,温。归脾、肾经。收敛止血,固精止带,制酸止痛,收湿敛疮。用于溃疡病,胃酸过多,吐血衄血,崩漏便血,遗精滑精,赤白带下,胃痛吞酸;外治损伤出血,疮多脓汁。
桂枝:味辛、甘,性温。归膀胱经,心经,肺经。发表解肌、温经通脉、助阳化气、平冲降气,属辛温解表药。
山药:性平,味甘。归脾经、肺经、肾经。补脾养胃、生津益肺、补肾涩精。属补虚药下属分类的补气药。
茯苓:性平,味甘、淡。归心经、肺经、脾经、肾经。利水渗湿、健脾宁心。属利水渗湿药下属分类的利水消肿药。
田七:味甘、微苦,性温。归肺、心、肝、大肠经。入血分,可散可收,祛瘀止血,消肿止痛。
儿茶:性微寒,味苦、涩。归肺经、心经。收湿、生肌、敛疮、止血。属止血药下属分类的收敛止血药。
本发明与现有技术相比,具有以下优点及有益效果:
本发明是基于对胃溃疡症状机理的认识及治疗原则,采用直接口服的方法,攻补兼施,具有强健脾胃、活血化瘀、益气养胃的效果,疗效显著,质量容易控制,稳定性好,基本无不良反应。
具体实施方式
下面结合实施例对本发明作进一步地详细说明,但本发明的实施方式不限于此。
实施例1:
如图1所示,一种能够治疗胃溃疡的中药配方,包括按重量计的蒲公英12~16份、黄芪12~20份、滑石15~19份、白花蛇10~12份、半夏10~15份、丹参10~16份、乌贼骨6~12份、桂枝6~10份、山药12~16份、茯苓10~18份、田七12~16份、儿茶8~14份。本发明用蒲公英、白花蛇有抗炎、抗Hp、促进炎症吸收的作用;使用丹参具有增加胃黏膜血流量、改善血循环的作用;使用乌贼骨、田七、儿茶,具有敛溃疡、护胃膜、制胃酸、生新肌的作用;使用黄芪、茯苓能够抗胃黏膜损伤,增加胃黏膜血流和PGE2,起到促进溃疡愈合作用;使用滑石有修复、保护受损粘膜的治疗作用。
本实施例药物制备的方法,包括以下几个步骤:
步骤S1:以重量份计,称取蒲公英12~16份、黄芪12~20份、滑石15~19份、白花蛇10~12份、半夏10~15份、丹参10~16份、乌贼骨6~12份、桂枝6~10份、山药12~16份、茯苓10~18份、田七12~16份、儿茶8~14份、黄芪10~16份;
步骤S2:将上述全部中药原料药,先行用清水或纯净水浸泡30分钟,浸泡用水量为0.9~1.1L;
步骤S3:将浸泡后的中药原料药物及其浸泡的药水加入到煎药容器中,加盖共同煎熬两小时,加药包括以下几个步骤:
步骤S301:先将蒲公英、黄芪、滑石、白花蛇加入到煎药容器中以小火煎煮10分钟;
步骤S302:再将半夏、丹参、乌贼骨、桂枝加入到煎药容器中以小火煎煮10分钟;
步骤S303:再将山药、茯苓、田七、儿茶加入到煎药容器中;
步骤S4:先用武火使煎药容器中药液沸腾,再使用文火熬制15~20分钟,煎药时需搅拌2~3次;
步骤S5:煎煮完成后,滤出药液,所获药液即为内服药物;
步骤S6:采用0.7~0.8L清水或纯净水重复步骤S3~S5进行第二次煎煮一小时;
采用0.5~0.6L清水或纯净水重复步骤S3~S5进行第三次煎煮一小时。
实施例2:
包括按重量计的蒲公英12份、黄芪20份、滑石15份、白花蛇10份、半夏15份、丹参10份、乌贼骨6份、桂枝6份、山药16份、茯苓18份、田七12份、儿茶14份。
实施例3:
包括按重量计的蒲公英16份、黄芪20份、滑石15份、白花蛇12份、半夏13份、丹参14份、乌贼骨10份、桂枝9份、山药16份、茯苓15份、田七16份、儿茶10份。
实施例4:
包括按重量计的蒲公英13份、黄芪16份、滑石17份、白花蛇11份、半夏14份、丹参12份、乌贼骨11份、桂枝8份、山药13份、茯苓14份、田七13份、儿茶11份。
毒理学试验:
急性毒性试验:
试验观察,因无法测出LD50,故进行了最大给药量的测定。将实施例1制备的中药复方合剂溶解在灭菌生理盐水中,配置成溶液灌胃小鼠,结果显示,以药物最大给药浓度9.65生药/ml,最大给药体积50ml/kg于24小时内给小鼠灌胃给药两次,小鼠最大给药量为763.25g生药/kg,动物未出现不良反应及死亡,解剖观察各脏器未见异常。
长期毒性试验:
本试验应用SD大鼠80只,将实施例1制备的中药复方合剂溶解在灭菌生理盐水中,配置成溶液灌胃,设对照组及24g、35g、49g生药/kg剂量组,连续灌胃给药12周,观察本发明的中药组合物对动物各项指标的影响。试验结果表明,连续给药12周,本发明的中药组合物对大鼠的体重、摄食量、外周血象、凝血时间、心电图、脏器指数等均无明显影响;血液生化十二项指标测定结果,给药12周低剂量组BiLi值高于对照组(P<0.05);低剂量组、中剂量组TP值高于对照组(P<0.05),但均在正常生理范围之内,其它指标与对照组比较无明显差异。恢复期各给药组各项指标测定值与对照组比较均无明显差异。各组各脏器大体观察未见异常。
利用本发明药物针对各种胃溃疡患者的临床统计资料:
经过50例患者的临床使用,其中男患者27,女患者23例,用药年龄对象20~50岁。其中最小21岁,最大49岁,平均年龄28岁。
张某,男,江苏人,48岁,一年前胃镜检查为多发性胃溃疡,临床症状以胃疼为主,近日疼痛加剧,并放射到后背、两肋及胸部,服雷尼替丁、洛赛克等药可使症状缓解,但停药后随即复发,患者服用本发明十天后胃疼缓解,大便正常,情绪稳定,精神较好。连续服药三个疗程后复检,溃疡愈合,继续服药巩固治疗一个月自今良好。
以上所述,仅是本发明的较佳实施例,并非对本发明做任何形式上的限制,凡是依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化,均落入本发明的保护范围之内。
Claims (5)
1.一种能够治疗胃溃疡的中药制备方法,其特征在于:包括以下几个步骤:
步骤S1:以重量份计,称取蒲公英12~16份、黄芪12~20份、滑石15~19份、白花蛇10~12份、半夏10~15份、丹参10~16份、乌贼骨6~12份、桂枝6~10份、山药12~16份、茯苓10~18份、田七12~16份、儿茶8~14份;
步骤S2:将上述全部中药原料药,先行用清水或纯净水浸泡30分钟,浸泡用水量为0.9~1.1L;
步骤S3:将浸泡后的中药原料药物及其浸泡的药水加入到煎药容器中,加盖共同煎熬;
步骤S4:先用武火使煎药容器中药液沸腾,再使用文火熬制15~20分钟,煎药时需搅拌2~3次;
步骤S5:煎煮完成后,滤出药液,所获药液即为内服药物。
2.根据权利要求1所述的一种能够治疗胃溃疡的中药制备方法,其特征在于:所述的步骤S3包括以下几个步骤:
步骤S301:先将蒲公英、黄芪、滑石、白花蛇加入到煎药容器中以小火煎煮10分钟;
步骤S302:再将半夏、丹参、乌贼骨、桂枝加入到煎药容器中以小火煎煮10分钟;
步骤S303:再将山药、茯苓、田七、儿茶加入到煎药容器中。
3.根据权利要求1所述的一种能够治疗胃溃疡的中药制备方法,其特征在于:所述的步骤S2~S5为第一次煎煮,还包括步骤S6:
采用0.7~0.8L清水或纯净水重复步骤S3~S5进行第二次煎煮;
采用0.5~0.6L清水或纯净水重复步骤S3~S5进行第三次煎煮。
4.根据权利要求3所述的一种能够治疗胃溃疡的中药制备方法,其特征在于:所述的第一次煎煮进行两小时,第二次煎煮进行一小时,第三次煎煮进行一小时。
5.根据权利要求1所述的一种能够治疗胃溃疡的中药制备方法,其特征在于:所述的煎药容器为砂锅、搪瓷器皿或者不锈钢,忌用铁器。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710756331.1A CN107468857A (zh) | 2017-08-29 | 2017-08-29 | 一种能够治疗胃溃疡的中药制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710756331.1A CN107468857A (zh) | 2017-08-29 | 2017-08-29 | 一种能够治疗胃溃疡的中药制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107468857A true CN107468857A (zh) | 2017-12-15 |
Family
ID=60603895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710756331.1A Withdrawn CN107468857A (zh) | 2017-08-29 | 2017-08-29 | 一种能够治疗胃溃疡的中药制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107468857A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201800005833A1 (it) * | 2018-05-30 | 2018-08-30 | Medicina per trattare gastroelcosi e relativo metodo di preparazione | |
IT201800007105A1 (it) * | 2018-07-11 | 2020-01-11 | Un farmaco per trattare gastroelcosi e suo metodo di preparazione |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105233233A (zh) * | 2015-11-19 | 2016-01-13 | 李�杰 | 一种治疗慢性胃溃疡的中药组合物及其制备方法 |
CN106581468A (zh) * | 2016-11-07 | 2017-04-26 | 成都泠汐尚品科技有限公司 | 一种能够治疗胃溃疡的中药制备方法 |
-
2017
- 2017-08-29 CN CN201710756331.1A patent/CN107468857A/zh not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105233233A (zh) * | 2015-11-19 | 2016-01-13 | 李�杰 | 一种治疗慢性胃溃疡的中药组合物及其制备方法 |
CN106581468A (zh) * | 2016-11-07 | 2017-04-26 | 成都泠汐尚品科技有限公司 | 一种能够治疗胃溃疡的中药制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201800005833A1 (it) * | 2018-05-30 | 2018-08-30 | Medicina per trattare gastroelcosi e relativo metodo di preparazione | |
IT201800007105A1 (it) * | 2018-07-11 | 2020-01-11 | Un farmaco per trattare gastroelcosi e suo metodo di preparazione |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107468857A (zh) | 一种能够治疗胃溃疡的中药制备方法 | |
CN104815318A (zh) | 一种治疗痛风的中药制剂 | |
CN102210818B (zh) | 治疗胃出血的中药 | |
CN103211990A (zh) | 一种治疗口腔溃疡的中药组合物 | |
CN104548029A (zh) | 一种治疗胃脘痛的药物组合物 | |
CN103830552A (zh) | 一种治疗美尼尔氏病的中药组合物 | |
CN102940693A (zh) | 治疗糖尿病足的药物组合物 | |
CN100534507C (zh) | 一种内服治疗慢性肠炎的中药组合物 | |
CN107744555A (zh) | 一种能够治疗胃溃疡的中药配方 | |
CN104623330A (zh) | 一种治疗高血脂的中药组合物 | |
CN106581468A (zh) | 一种能够治疗胃溃疡的中药制备方法 | |
CN102940677A (zh) | 治疗糖尿病足的药物组合物 | |
CN114272329B (zh) | 一种治疗肝肾不足型颈椎病的中药组合物、制剂与应用 | |
CN103007170B (zh) | 一种治疗复发性口腔溃疡的中药组合物 | |
CN106389782A (zh) | 一种治疗乳痈的中药组合物 | |
CN105079661A (zh) | 一种治疗便血的中药组合物 | |
CN105079094A (zh) | 一种治疗便血的中药组合物 | |
CN106581469A (zh) | 一种能够治疗胃溃疡的中药配方 | |
CN104435979B (zh) | 一种治疗风湿腰腿疼痛的药物 | |
CN112972611A (zh) | 一种治疗溶血性贫血的药物组合物及其应用 | |
CN107519419A (zh) | 一种有效治疗腰酸疼痛的中药组合物 | |
CN115624586A (zh) | 一种治疗激素依赖性哮喘的中药组合物以及应用 | |
CN107519421A (zh) | 一种有效治疗腰酸疼痛的中药组合物的制备方法 | |
CN117414351A (zh) | 用于治疗脾肾阳虚便秘的中药贴剂及其制备方法和应用 | |
CN110680849A (zh) | 一种口服治疗骨折的中药配方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20171215 |
|
WW01 | Invention patent application withdrawn after publication |